| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/19/2005 | CN1568207A 2-amino-6-(2, 4, 5-substituted-phenyl)-pyridines |
| 01/19/2005 | CN1568198A Use of cd23 antagonists for the treatment of neoplastic disorders |
| 01/19/2005 | CN1568197A Composite superimmunogen for bi-functional vaccine use for the treatment of illnesses associated with a stromal tissue disorder |
| 01/19/2005 | CN1568192A Kahalalide F formulation |
| 01/19/2005 | CN1568187A 2H-2, 3-dinitrogen phenodiazine-1-ketone and using method thereof |
| 01/19/2005 | CN1568178A Injectable composition of paclitaxel |
| 01/19/2005 | CN1566356A Method for preparing earthworm bioactive peptide and earthworm biological micro-fertilizer and use thereof |
| 01/19/2005 | CN1566348A G type non-viral vector and pharmaceutical composition containing same |
| 01/19/2005 | CN1566347A N type non-viral vector and pharmaceutical composition containing same |
| 01/19/2005 | CN1566330A Activated HLA semi-coincident allogene mixed hematopoietic stem cell and method for making same |
| 01/19/2005 | CN1566160A Mu Shen polysaccharide and its immunoregulation and anticancer function |
| 01/19/2005 | CN1566156A Recombinant target fusion protein GnRH-TNFam and its antitumor use |
| 01/19/2005 | CN1566151A Sugar latticeing material CHB extracted from serum of turtle or/and tortoise, preparation process and application in pharmacy thereof |
| 01/19/2005 | CN1566149A Immunosuppressive receptor derived from dendritic cell, coded sequence and uses thereof |
| 01/19/2005 | CN1566148A Tumor suppressor, coded protein and application thereof |
| 01/19/2005 | CN1566136A Pasqueflower notoginsenosides and extraction method, medicinal uses and pharmaceutical preparation thereof |
| 01/19/2005 | CN1566130A Nucleoside analogue lipid derivative and salt thereof |
| 01/19/2005 | CN1566115A 2 beta-substituted indian apple derivative and preparation method thereof |
| 01/19/2005 | CN1566061A Novel natural drug effective region of rabdosiaexcisa total diterpene |
| 01/19/2005 | CN1565627A Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferation |
| 01/19/2005 | CN1565622A Therapeutic agent to recover hematopoiesis function and its compositions and usage |
| 01/19/2005 | CN1565621A Obtainment of cell growth inhibiting polypeptide and its usage |
| 01/19/2005 | CN1565601A Application of sichuan lovage rhizome oil by supercritical CO2 extraction method in pharmacy |
| 01/19/2005 | CN1565589A Abdominal mass eliminating pill |
| 01/19/2005 | CN1565528A Medicine for treating ovary cyst and its preparing process |
| 01/19/2005 | CN1565517A Preparing method of nanometer level high purity freeze dried powder of aloe and its preparation |
| 01/19/2005 | CN1565500A Chinese traditional medicine for treating thyroid malignant tumor |
| 01/19/2005 | CN1565476A Iodine ion injection liquid |
| 01/19/2005 | CN1565473A Water soluble nightshade extract, its preparation method and pharmaceutical compositions |
| 01/19/2005 | CN1565468A S.japonica (Sw.) Ohwi flavone glucoside capsule and its production method |
| 01/19/2005 | CN1565466A S.japonica (Sw.) Ohwi flavone glucoside injection and its preparing process |
| 01/19/2005 | CN1565436A Retinoic acid release control nanomicrosphere and its preparation method |
| 01/19/2005 | CN1565432A Use of gossypol and its derivative in preparation of drug for leukemia / bone marrow cancer |
| 01/19/2005 | CN1565430A Allicin cyclodextrin clathrate compound, formulation and its preparation method |
| 01/19/2005 | CN1565427A Gastric 5-fluorouracil double slow release tablet of float and stay type for curing gastric cancer |
| 01/19/2005 | CN1565159A Clitotybegiganter mycelium and its cultivation method and uses |
| 01/19/2005 | CN1185348C Chimeric interleukin-6 soluble receptor/ligand protein and application thereof |
| 01/19/2005 | CN1185261C Interleukin -2/granulocyte-macrophage colony stimulating factor fusion protein |
| 01/19/2005 | CN1185252C Somatostatin peptides |
| 01/19/2005 | CN1185251C Novel LHRH-antagonists with improved solubility characteristics |
| 01/19/2005 | CN1185250C Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 01/19/2005 | CN1185247C Process for preparing indolopyrrolocarbazole derivatives, intermediates therefor, and preparation process of the intermediates |
| 01/19/2005 | CN1185233C Aryl and heteroaryl diazabicycloalkanes, their preparation and use |
| 01/19/2005 | CN1185232C Inhibitors of alpha L beta 2 mediated cell adhesion |
| 01/19/2005 | CN1185229C 3-indolyl-4-phenyl-1H-pyrrole-2, 5-dione derivatives as inhibitors of glycogen synthase kinase-3beta |
| 01/19/2005 | CN1185227C Novel compounds |
| 01/19/2005 | CN1185215C Substituted glutarimides and use as IL-12 production inhibitors thereof |
| 01/19/2005 | CN1185214C Novel indeno indolone compound, its preparation method and drug composition comprising the same |
| 01/19/2005 | CN1185213C Azetidine derivatives, preparation and pharmaceutical compositions thereof |
| 01/19/2005 | CN1185006C Chinese medicine composition for accessory treatment of primary liver cancer and preparing method thereof |
| 01/19/2005 | CN1184988C Chinese medicine for treating liver cancer, pancreatic cancer and other malignant tumors |
| 01/19/2005 | CN1184985C Tumor treating capsule and its inspecting method thereof |
| 01/19/2005 | CN1184962C Sertraline oral condensate |
| 01/19/2005 | CN1184957C Intravaginal drug delivery devices for adminsitration of testosterone and testosterone precursors |
| 01/18/2005 | US6844466 Treating or preventing emphysema, cancer and dermatological disorders |
| 01/18/2005 | US6844457 Antiproliferative agents; anticancer agents; antiinflammatory agents |
| 01/18/2005 | US6844445 Central nervous system disorders; psychological disorders |
| 01/18/2005 | US6844439 Process for the preparation of imidazole compounds |
| 01/18/2005 | US6844435 Heterocyclic compounds useful as inhibitors of tyrosine kinases |
| 01/18/2005 | US6844434 Synthesis of temozolomide and analogs |
| 01/18/2005 | US6844429 Fullerene derivative and composition comprising the same |
| 01/18/2005 | US6844422 Inhibitor protein of the wnt signal pathway |
| 01/18/2005 | US6844349 Salt forms of E-2-methoxy-N-(3-{4-[3 methyl-4-(6-methyl-pyridin-3-yloxy)-phenylamino]-quinazolin-6-yl}-allyl)-acetamide and method of production |
| 01/18/2005 | US6844343 N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent |
| 01/18/2005 | US6844341 Cell cycle kinase inhibitors; such as 2-(4-(N-(2-methoxy-ethyl)-sulphamoyl)anilino)-4-(imidazo(1,2b)pyridazin-3 -yl)-pyrimidine |
| 01/18/2005 | US6844336 4-fluoroalkyl-2h-benzopyrans with anti-estogenic activity |
| 01/18/2005 | US6844335 2-amino-3-(alkyl)-pyrimidone derivatives as GSK3.β.inhibitors |
| 01/18/2005 | US6844332 (20S)-1α-hydroxy-2α-methyl and 2β-methyl-19-nor-vitamin D3 and their uses |
| 01/18/2005 | US6844331 (20S)-1α-hydroxy-2α-methyl and 2β-methyl-19-nor-vitamin D3 and their uses |
| 01/18/2005 | US6844330 (20S)-1α-hydroxy-2α-methyl and 2β-methyl-19-NOR-vitamin D3 and their uses |
| 01/18/2005 | US6844329 Synthetic oligo- and polysaccharides exhibiting at least one covalent bond with biotin or a biotin derivative and having the anticoagulant and antithrombotic pharmacological activities of heparin |
| 01/18/2005 | US6844328 Antiproliferative activity; low systemic toxicity; psoriasis, tumors, rheumatoid arthritis, intestinal inflammation |
| 01/18/2005 | US6844323 Polypeptide-calcitonin 11 and the polynucleotide encoding it |
| 01/18/2005 | US6844318 Peptidase-cleavable, targeted antineoplastic drugs and their therapeutic use |
| 01/18/2005 | US6844189 Chromosome 17P-linked prostate cancer susceptibility gene |
| 01/18/2005 | US6844180 Nucleotide sequences for use in the treatment of viral diseases, hypertension and coagulation defects |
| 01/18/2005 | US6844153 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin |
| 01/18/2005 | US6843989 Administering a CD40 binding protein that potentiates the binding of CD40 to CD40 ligand |
| 01/18/2005 | CA2269638C Ice inhibiting peptides |
| 01/13/2005 | WO2005003776A2 In vitro methods for detecting renal cancer |
| 01/13/2005 | WO2005003335A2 Rapamycin resistant t cells and therapeutic uses thereof |
| 01/13/2005 | WO2005003177A2 Molecules for the targeting and the in situ assembly of therapeutic proteins and use thereof |
| 01/13/2005 | WO2005003156A1 Polypeptides having binding affinity for her2 |
| 01/13/2005 | WO2005003130A1 Novel pyrrolodihydroisoquinolines useful in the treatment of cancer |
| 01/13/2005 | WO2005003129A1 Pyrrolodihydroisoquinolines as pde10 inhibitors |
| 01/13/2005 | WO2005003120A2 Metabolites of tricyclic amides useful for inhibition of g-protein function and methods of treatment of proliferative diseases |
| 01/13/2005 | WO2005003114A1 5-fluoro-thiopen-compounds,the process for their preparation,the pharmaceutical compositions containing them and their use as metallopotenases inhibitors |
| 01/13/2005 | WO2005003102A1 Methods of preparation of dehydro-diketopiperazines in liquid phase or of solid supported phase |
| 01/13/2005 | WO2005002673A1 Raf kinase inhibitors |
| 01/13/2005 | WO2005002672A2 Sirt1 modulators for manipulating cells/organism lifespan/stress response |
| 01/13/2005 | WO2005002629A1 Combination therapy of oxaliplatin and radioactively doped particles treating cancer |
| 01/13/2005 | WO2005002623A1 Remedy for sarcoidosis and method of treating the same |
| 01/13/2005 | WO2005002607A2 Oncolytic reoviruses for the treatment of neoplasms having activated pp2a or rac |
| 01/13/2005 | WO2005002604A1 Pharmaceutical active ingredient to combat tumours |
| 01/13/2005 | WO2005002594A1 An anti-tumor rna interference drug for multidrug resistance |
| 01/13/2005 | WO2005002590A1 Agent inducing increase in bone mass |
| 01/13/2005 | WO2005002584A1 Use of roscovitine for treating lymphocytic leukemia |
| 01/13/2005 | WO2005002582A2 Trp-p8 active compounds and therapeutic treatment methods |
| 01/13/2005 | WO2005002579A1 Pyrrolo-dihydroisoquinoline derivatives as pde10 inhibitors |
| 01/13/2005 | WO2005002576A2 Imidazole derivatives and their use as protein kinases inhibitors |